Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

Click for more information

1.41%

35.0¢ botanix pharmaceuticals ltd

Ann: Investor Webinar Presentation, page-46

First 46 Last

Share
Profile

Follow
Lev20

2,617 Posts.

613

10/06/23

22:09

Post #: 68234563
Share

Originally posted by WizardOz: ↑

Qbrexza hasn’t had commercial success, but there’s facts from Qbrexza’s history that support BOT’s claims for the need for, and market, of a hyperhydrosis treatment

- 6 Pharmaceutical companies invested in Qbrexza. (Ownership of Qbrexza from 2005 Connetics > 2006 Stiefel > 2009 GlaxoSmithKline (shelved due to concerns over the safety of Glycopyrronium) > 2014 Dermira (FDA approval June 2018) > 2020 Eli Lilly > 2021 Journey Medical Corp)

- The FDA approved Qbrexza

-Within a year of FDA approval 80% of commercial lives had insurance coverage for Qbrexza

-There was growth in the amount of prescriptions over the first year 14,500 Q4 2018 > 23,559 prescriptions in Q1 2019 > 28,609 prescriptions in Q2 2019 > 32,646 prescripti- ons in Q3 2019

And I think that it is worth mentioning that Dermira’s advertising campaign for the first year was unbranded, they spent tens of millions of dollars on the ‘know your sweat’ campaign to educate/change public perception because the public didn’t consider hyperhidrosis a medical condition, and therefore weren’t seeking medical treatment. Their branded ad’s started in May 2019.

Expand

Sales of Anything over 70mln just in a first yeat will give us over 1bln valation

BOT Price at posting: 9.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

NSM

North Stawell Minerals set to raise $1.3M in capital raising for exploration in Victoria

CRI

Critica unveils fresh REE hits near Jupiter play in WA – and 5 new prospects

SGR

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

THB

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 24 more messages in this thread...

First 46 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 35.0¢		Change -0.005(1.41%)		Mkt cap ! $636.1M

Open	High	Low	Value	Volume
35.5¢	36.0¢	34.0¢	$2.246M	6.430M

Buyers (Bids)

No.	Vol.	Price($)
3	54114	35.0¢

Sellers (Offers)

Price($)	Vol.	No.
35.5¢	80800	5

View Market Depth

No.	Vol.	Price($)
3	54114	0.350
2	192220	0.345
20	638363	0.340
8	154350	0.335
11	314325	0.330

Price($)	Vol.	No.
0.355	80800	5
0.360	210908	5
0.365	566485	7
0.370	18000	1
0.375	388137	6

Last trade - 16.10pm 17/10/2024 (20 minute delay)

BOT (ASX) Chart

SPONSORED BY